Invizyne Technologies Inc. (IZTC)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	67.20M
Revenue (ttm)	n/a
Net Income (ttm)	-1.33M
Shares Out	16.80M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IZTC

Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals. Our objective with SimplePath™, our biomanufacturing platform, is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. We believe that SimplePath™ not only can maximize the value of these resources but also will contribute to the development of novel chemical compo...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2019
• Employees: 29
• Stock Exchange: NASDAQ
• Ticker Symbol: IZTC